University of Campania Luigi Vanvitelli: Diabetes Mellitus, Type 2 trials

The registry lists 14 Diabetes Mellitus, Type 2 studies with University of Campania Luigi Vanvitelli as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 4 8No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Liraglutide and Peripheral Artery DiseaseCompletedNCT04881110Phase 4Results posted
• DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 DiabetesCompletedNCT01472432Phase 4Results posted
• Nephropathy In Type 2 Diabetes and Cardio-renal EventsCompletedNCT00535925Phase 4Results posted
• GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.CompletedNCT06017544
• Ghrelin and Diastolic Heart FunctionCompletedNCT05988346
• Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)CompletedNCT04196231Phase 4
• Molecular Mechanisms and Carotid AtherosclerosisCompletedNCT03962686
• Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)CompletedNCT03918148
• SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.CompletedNCT03366181
• SGLT2i and Incretin and CRTd.CompletedNCT03282136Phase 4
• Glycemic Durability After Metformin FailureStatus unknownNCT02142309Phase 4
• Pioglitazone Versus Metformin in Type 2 DiabetesCompletedNCT00815399Phase 4
• Dietary Control of Type 2 Diabetes: Low-Carbohydrate Mediterranean Diet Versus Low-Fat DietCompletedNCT00725257Not applicable
• Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 DiabetesCompletedNCT00641407Phase 4